Back
Cidara Therapeutics Stock Price Chart
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Buy
62
CDTX
Cidara Therapeutics
Last Price:
14.66
Seasonality Move:
7.85%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight buying pressure.
Cidara Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.55 | Buy |
| 20-day SMA: | 12.76 | Buy |
| 50-day SMA: | 11.74 | Buy |
| 200-day SMA: | 12.96 | Buy |
| 8-day EMA: | 13.62 | Buy |
| 20-day EMA: | 12.9 | Buy |
| 50-day EMA: | 12.24 | Buy |
| 200-day EMA: | 13.18 | Buy |
Cidara Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.68 | Buy |
| Relative Strength Index (14 RSI): | 75.01 | Buy |
| Chaikin Money Flow: | 12591 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.1 - 13.56) | Buy |
| Bollinger Bands (100): | (11.03 - 12.91) | Buy |
Cidara Therapeutics Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cidara Therapeutics Stock
Is Cidara Therapeutics Stock a Buy?
- Cidara Therapeutics share price is 14.48 while CDTX 8-day simple moving average is 13.55, which is a Buy signal.
- The stock price of CDTX is 14.48 while Cidara Therapeutics 20-day SMA is 12.76, which makes it a Buy.
- Cidara Therapeutics 50-day simple moving average is 11.74 while CDTX share price is 14.48, making it a Buy technically.
- CDTX stock price is 14.48 and Cidara Therapeutics 200-day simple moving average is 12.96, creating a Buy signal.
CDTX Technical Analysis vs Fundamental Analysis
Buy
62
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy or a Sell?
-
Cidara Therapeutics stock is rated a Buy
The current Cidara Therapeutics [CDTX] share price is $14.48. The Score for CDTX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Cidara Therapeutics Stock Info
Market Cap:
102.03M
Price in USD:
14.48
Share Volume:
30.03K
Cidara Therapeutics 52-Week Range
52-Week High:
24.40
52-Week Low:
10.00
Buy
62
Cidara Therapeutics (CDTX)
is a Buy
Cidara Therapeutics Share Price Forecast
-
What is the Cidara Therapeutics stock price today?
The Cidara Therapeutics stock price is 14.48 USD today. -
Will CDTX stock go up or go down?
Cidara Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Cidara Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cidara Therapeutics is not overvalued.
Is Cidara Therapeutics Stock a Buy?
- Cidara Therapeutics share price is 14.48 while CDTX 8-day exponential moving average is 13.62, which is a Buy signal.
- The stock price of CDTX is 14.48 while Cidara Therapeutics 20-day EMA is 12.90, which makes it a Buy.
- Cidara Therapeutics 50-day exponential moving average is 12.24 while CDTX share price is 14.48, making it a Buy technically.
- CDTX stock price is 14.48 and Cidara Therapeutics 200-day simple moving average is 13.18, creating a Buy signal.
Fundamental Analysis of Cidara Therapeutics
Is Cidara Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $1.97 per share, a decrease next quarter of $0.00 per share, a decrease this year of $18.96 per share, and an increase next year of $15.14 per share.
Technical Analysis of Cidara Therapeutics
Should I short Cidara Therapeutics stock?
- CDTX Moving Average Covergence Divergence (MACD) indicator is 0.68, suggesting Cidara Therapeutics is a Buy
- Cidara Therapeutics Relative Strength Index (RSI) is 75.01, which suggest Cidara Therapeutics is overbought
- The Bollinger Bands (25) for Cidara Therapeutics is (11.1 - 13.56), which suggest Cidara Therapeutics is a Buy
- The Bollinger Bands (100) for Cidara Therapeutics is (11.03 - 12.91), which suggest Cidara Therapeutics is a Buy
* Cidara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.